Current thinking has long been that group therapy contributes positively to the life extension of people with advanced cancer. In a landmark study (1989) by Stanford University psychiatrist David Spiegel, it was reported that group therapy doubled the lives of women with metastatic breast cancer. In contradiction to this finding a recent study, reported in [...]
Patient Advocate Foundation's Co-Pay Relief (CPR) Program provides direct co-payment assistance to men with prostate cancer as well many other serious illnesses. Financial assistance is for pharmaceutical products to insured Americans who financially and medically qualify. They welcome Medicare Part D beneficiaries who require assistance with their pharmaceutical co-payments. The Program offers personal service to [...]
Tomorrow morning we're leaving for our Third annual beach vacation. Yippee. If you're on I-95 tomorrow I'll be the stressed out looking guy with the amazing hair that turns gray right before your eyes, my son will be eating his 879th chicken nugget, and my wife will probably be driving. I'm sure it'll be fine, [...]
In the June 2007 edition of Harper's Magazine there is a very interesting article entitled "Chemo World, Surviving the Cancer Unit" by Sallie Tisdale. The article is written from a general cancer perspective. What makes this article a little different is that Ms Tisdale is an oncology nurse at Providence Portland Medical Center in Portland, [...]
Taxotere® (Docetaxel) plus Estramustine Confirmed Superior to Taxotere Alone for Hormone Refractory Prostate Cancer A recent multi-center U.S. clinical trial has concluded that Taxotere and Estramustine improved survival of men with hormone refractory prostate cancer (HRPC) when compared to the standard regimen of Mitoxantrone and Prednisone. In addition, a recent French trial reported that a [...]